Butterfly-like photo-responsive cyclometalated Ir(iii) complex: emergence of a future cancer therapeutic agent

Abstract

Herein, we report photoinduced 2,2′-bipyrimidine-based mono- and binuclear cyclometalated iridium(III) complexes as a future promising anticancer agent, exhibiting the best efficiency as type I and type II PDT agents, respectively. The bimetallic complex LIr2 exhibits superior efficacy in normoxic (type II) and hypoxic (type I) tumour conditions, while the monometallic complex LIr is mainly active under normoxic conditions. This enhanced versatility makes LIr2 a highly promising candidate for photodynamic therapy. The complexes exhibited high serum albumin binding affinity (KHSA = 0.57 × 105 M−1 for LIr and 0.59 × 105 M−1 for LIr2), highlighting their significant potential for biomolecular interactions. Under specific light irradiation, these complexes deplete glutathione levels, proving their efficacy as photodynamic therapeutic agents in future. Among the two synthesized complexes, LIr2 showed significant phototoxicity against the TNBC cell line (MDA-MB-231), exhibiting an IC50 value of 13.6 ± 0.06 μM (PI = 9.9), highlighting its potential as an effective PDT agent.

Graphical abstract: Butterfly-like photo-responsive cyclometalated Ir(iii) complex: emergence of a future cancer therapeutic agent

Supplementary files

Transparent peer review

To support increased transparency, we offer authors the option to publish the peer review history alongside their article.

View this article’s peer review history

Article information

Article type
Paper
Submitted
17 May 2025
Accepted
26 Aug 2025
First published
01 Sep 2025

Dalton Trans., 2025, Advance Article

Butterfly-like photo-responsive cyclometalated Ir(III) complex: emergence of a future cancer therapeutic agent

S. U, R. Das, I. P. Latha Laxmi, N. Roy, R. Roy, L. Mathivathanan, T. Ramasamy, R. Chakrabarty and P. Paira, Dalton Trans., 2025, Advance Article , DOI: 10.1039/D5DT01164G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements